EdgeRock Capital LLC Acquires New Holdings in HCA Healthcare, Inc. (NYSE:HCA)

EdgeRock Capital LLC acquired a new position in HCA Healthcare, Inc. (NYSE:HCA) during the 4th quarter, HoldingsChannel.com reports. The firm acquired 172 shares of the company’s stock, valued at approximately $47,000.

Several other institutional investors have also recently added to or reduced their stakes in HCA. Northern Trust Corp boosted its stake in shares of HCA Healthcare by 3.2% in the third quarter. Northern Trust Corp now owns 2,152,419 shares of the company’s stock valued at $529,452,000 after purchasing an additional 67,332 shares during the period. Morgan Stanley raised its stake in shares of HCA Healthcare by 1.4% in the third quarter. Morgan Stanley now owns 2,150,009 shares of the company’s stock valued at $528,860,000 after acquiring an additional 30,072 shares in the last quarter. Invesco Ltd. increased its holdings in HCA Healthcare by 5.0% during the 3rd quarter. Invesco Ltd. now owns 2,146,844 shares of the company’s stock worth $528,081,000 after purchasing an additional 102,025 shares during the period. Diamond Hill Capital Management Inc. boosted its stake in shares of HCA Healthcare by 3.7% in the 3rd quarter. Diamond Hill Capital Management Inc. now owns 1,594,344 shares of the company’s stock valued at $392,177,000 after buying an additional 57,390 shares during the period. Finally, Charles Schwab Investment Management Inc. raised its holdings in HCA Healthcare by 0.6% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,126,550 shares of the company’s stock valued at $304,935,000 after acquiring an additional 6,407 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Buying and Selling at HCA Healthcare

In other news, SVP Chad J. Wasserman sold 876 shares of HCA Healthcare stock in a transaction dated Wednesday, March 20th. The stock was sold at an average price of $330.25, for a total value of $289,299.00. Following the transaction, the senior vice president now directly owns 1,576 shares in the company, valued at $520,474. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, EVP Michael S. Cuffe sold 1,600 shares of the stock in a transaction on Monday, May 6th. The stock was sold at an average price of $309.00, for a total transaction of $494,400.00. Following the sale, the executive vice president now owns 34,124 shares in the company, valued at $10,544,316. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Chad J. Wasserman sold 876 shares of the firm’s stock in a transaction dated Wednesday, March 20th. The shares were sold at an average price of $330.25, for a total transaction of $289,299.00. Following the completion of the sale, the senior vice president now owns 1,576 shares of the company’s stock, valued at approximately $520,474. The disclosure for this sale can be found here. Insiders have sold a total of 8,055 shares of company stock worth $2,503,100 over the last three months. Corporate insiders own 1.70% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on HCA shares. Oppenheimer lifted their price objective on shares of HCA Healthcare from $330.00 to $345.00 and gave the stock an “outperform” rating in a research report on Monday, April 29th. Truist Financial upped their price target on HCA Healthcare from $320.00 to $345.00 and gave the company a “buy” rating in a report on Wednesday, January 31st. Barclays boosted their price objective on shares of HCA Healthcare from $356.00 to $367.00 and gave the stock an “overweight” rating in a research report on Monday, April 29th. Wells Fargo & Company boosted their price target on shares of HCA Healthcare from $303.00 to $315.00 and gave the company an “equal weight” rating in a research report on Thursday, March 28th. Finally, TD Cowen cut their target price on HCA Healthcare from $371.00 to $360.00 and set a “buy” rating on the stock in a research report on Tuesday, April 30th. Four analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and an average target price of $316.59.

HCA Healthcare Stock Performance

HCA stock traded down $5.03 on Wednesday, reaching $309.42. The company’s stock had a trading volume of 1,023,674 shares, compared to its average volume of 1,096,014. The firm has a fifty day moving average of $321.53 and a two-hundred day moving average of $298.85. The company has a market capitalization of $81.04 billion, a P/E ratio of 15.42, a price-to-earnings-growth ratio of 1.44 and a beta of 1.66. The company has a debt-to-equity ratio of 29.26, a current ratio of 1.16 and a quick ratio of 1.02. HCA Healthcare, Inc. has a 52 week low of $215.96 and a 52 week high of $335.83.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, April 26th. The company reported $5.36 EPS for the quarter, beating analysts’ consensus estimates of $5.01 by $0.35. The company had revenue of $17.34 billion during the quarter, compared to the consensus estimate of $16.81 billion. HCA Healthcare had a return on equity of 674.49% and a net margin of 8.20%. The company’s quarterly revenue was up 11.2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $4.93 EPS. As a group, analysts predict that HCA Healthcare, Inc. will post 20.74 EPS for the current fiscal year.

HCA Healthcare announced that its Board of Directors has approved a stock repurchase program on Tuesday, January 30th that allows the company to buyback $6.00 billion in shares. This buyback authorization allows the company to buy up to 7.4% of its stock through open market purchases. Stock buyback programs are generally an indication that the company’s board of directors believes its shares are undervalued.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, June 28th. Shareholders of record on Friday, June 14th will be paid a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a yield of 0.85%. The ex-dividend date is Friday, June 14th. HCA Healthcare’s dividend payout ratio (DPR) is presently 13.16%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.